stemmacstm ipsc mrna reprogramming kit (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
94
Structured Review
Miltenyi Biotec
stemmacstm ipsc mrna reprogramming kit
Stemmacstm Ipsc Mrna Reprogramming Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stemmacs+mrna+reprogramming+kit/StemMACS+iPSC+mRNA+Reprogramming+Kit%2C+human/pmc13322296-78-28-33
Average 94 stars, based on 2 article reviews
Stemmacstm Ipsc Mrna Reprogramming Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stemmacs+mrna+reprogramming+kit/StemMACS+iPSC+mRNA+Reprogramming+Kit%2C+human/pmc13322296-78-28-33
Average 94 stars, based on 2 article reviews
stemmacstm ipsc mrna reprogramming kit - by Bioz Stars,
2026-09
94/100 stars
Images
1) Product Images from "Human iPSCs derived from cryopreserved testicular somatic cells enable germline regeneration in childhood cancer survivors"
Article Title: Human iPSCs derived from cryopreserved testicular somatic cells enable germline regeneration in childhood cancer survivors
Journal: Human Reproduction Open
doi: 10.1093/hropen/hoag054
Figure Legend Snippet: Overview of the experimental layout: focus on primary testicular somatic cell cultures and reprogramming . ( A ) Schematic overview of the experimental procedures. ( B ) Non-genome-integrating, feeder-free reprogramming of human induced pluripotent stem cells (hiPSCs) from primary testicular somatic cells, with the corresponding time required for each step. Left panel: Phase-contrast images of confluent primary testicular somatic cell cultures approximately 1 week after isolation from the cryopreserved tissue; Middle panel: Emerging hiPSC colonies following the mRNA-based reprogramming protocol; Right panel: Expansion of the isolated hiPSC clones NFKI001 at passage 8 (p8) and NFKI002 at p15 from Patients 1 and 2, respectively. Scale bars, 500 μm. Figure (A) was created using BioRender (Alves Lopes, J. P. (2026); https://BioRender.com/gv6k171 ).
Techniques Used: Isolation, Clone Assay
Related Articles
Generated:Article Title: Small fibre neuropathy in Fabry disease: a human-derived neuronal in vitro disease model Article Snippet: Briefly, dermis and epidermis were mechanically separated and the dermal part was collected in fibroblast cultivation medium (DMEM/F12 + 100 U/ml penicillin 100 μg/ml streptomycin [pen/strep; both: Thermo Fisher Scientific, Waltham, MA, USA] + 10% fetal calf serum [FCS; Merck, Darmstadt, Germany]). .. All cell lines were cultivated at 37°C with 5% CO 2 (v/v). iPSC were generated using the StemRNA 3 rd Gen reprogramming kit (Reprocell, Maryland, USA) for all male cell lines (FD-1, FD-2, Ctrl) and the Article Title: Small fibre neuropathy in Fabry disease: a human-derived neuronal in vitro disease model and pilot data Article Snippet: Briefly, dermis and epidermis were mechanically separated, and the dermal part was collected in fibroblast cultivation medium [Dulbecco's Modified Eagle Medium, DMEM/F12 + 100 U/ml penicillin 100 μg/ml streptomycin (pen/strep; both: Thermo Fisher Scientific, Waltham, MA, USA) + 10% fetal calf serum (FCS; Merck, Darmstadt, Germany)]. .. All cell lines were cultivated at 37°C with 5% CO 2 (v/v). iPSC were generated using the StemRNA 3rd Gen reprogramming kit (Reprocell, Beltsville, MD, USA) for all male cell lines (FD-1, FD-2 and Ctrl) and the Transfection:Article Title: Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes Article Snippet: .. The Article Title: Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes Article Snippet: Reprogramming factors were delivered as modified mRNAs (mmRNAs) taking advantage of a microfluidic system ( ). .. The |